impact of re-tur on bcg-treated t1 hg/g3 bladder cancer
Published 8 years ago • 1.1K plays • Length 2:38Download video MP4
Download video MP3
Similar videos
-
15:03
t1 bladder cancer
-
28:30
high grade non muscle invasive bladder cancer: stages and treatment including bcg
-
28:32
bcg treatment for high grade, non-muscle invasive bladder cancer
-
3:01
significance of time interval between 1st & 2nd tur in bladder cancer treated with intravesical bcg
-
10:00
bcg treatment for non-muscle invasive bladder cancer
-
21:04
bcg unresponsive non-muscle invasive bladder cancer
-
2:03
the evolution of bladder cancer treatment and the immuno-oncology era
-
2:07
bladder cancer treatment: turbt
-
10:43
uropatient 19: bcg treatment for bladder cancer
-
4:19
novel biomarkers for outcomes identified in bcg-treated t1hg bladder cancer
-
7:41
bcg-refractory superficial bladder cancer
-
4:54
use of bcg in non-muscle-invasive bladder cancer
-
1:48
dr. ramos on the role of bcg in non-muscle invasive bladder cancer
-
27:09
detail: chemotherapy & immunotherapy (bcg) for non muscle invasive bladder cancer
-
52:27
optimizing bladder cancer treatment during the bcg shortage era
-
14:50
bcg unresponsive disease
-
39:23
urowebinar: is immune therapy changing the way we think about early bladder cancer?
-
50:41
management of bcg-unresponsive non-muscle invasive bladder cancer
-
1:18
investigating novel treatment options for bcg-unresponsive urothelial carcinoma